Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8400 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025. Written by Jing Xian and 10 co-authors. Institution: State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine, Chengdu, China. Major MEDLINE topics: Anti-Obesity Agents, Obesity, Phytochemicals. Cited 5 times so far (Crossref); 244 references. Funded by: State Administration of Traditional Chinese Medicine of the People's Republic of China, National Natural Science Foundation of China.
Abstract (original language)
Obesity is a metabolic disorder that has become a global health concern. The existing pharmaceutical drugs for treating obesity have some side effects. Compounds from natural sources are prospective substitutes for treating chronic diseases such as obesity, with the added advantages of being safe and cost‐effective. However, due to factors such as poor solubility, low bioavailability, and instability in the physiological environment, the therapeutic efficacy of phytoconstituents is limited. Nowadays, developing nanoscaled systems has emerged as a vital strategy for enhancing the delivery and therapeutic effect of phytoconstituents. The present study discusses and categorizes phytoconstituents with anti‐obesity effects and concludes the main mechanisms underlying their effects. Importantly, strategies used to develop phytoconstituent‐based nano‐drug delivery systems (NDDS) for obesity treatment that show improved efficacy relative to traditional administration routes are reviewed. Finally, the progress of research on phytoconstituent‐based NDDS for obesity treatment is summarized to provide a reference for the development of safe and effective treatment strategies for obesity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Southwestern Chinese Medicine Resources, Pharmacy School, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Science, Beijing, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
- Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, Hong Kong Polytechnic University, Hong Kong SAR, China.
ORCID profiles: Jingjing Li, Jinming Zhang
Funding
- State Administration of Traditional Chinese Medicine of the People's Republic of China
- National Natural Science Foundation of China
Cite
APA
Xian, J., Huang, Y., Bai, J., Liao, Q., Chen, Q., Cheng, W., Su, Z., Li, S., Wu, Y., Li, J., & Zhang, J. (2025). Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems. Phytotherapy Research. https://doi.org/10.1002/ptr.8400
Vancouver
Xian J, Huang Y, Bai J, Liao Q, Chen Q, Cheng W, et al. Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems. Phytotherapy Research. 2025. doi:10.1002/ptr.8400
BibTeX
@article{Xian2025,
author = {Xian, Jing and Huang, Yu and Bai, Jinrong and Liao, Qian and Chen, Qiyan and Cheng, Weijian and Su, Ziye and Li, Siyao and Wu, Yihan and Li, Jingjing and Zhang, Jinming},
title = {Recent Advances in the Anti‐Obesity Benefits of Phytoconstituents: From Phytochemistry to Targeting Novel‐Systems},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8400}
}
EUVIMED